The antiinflammatory, antinociceptive and gastroprotective effects of peptidoleukotriene receptor blockers

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The role of peptidoleukotrienes and their receptors in the inflammatory pain and rheumatoid arthritis oedema is steel unclear and has to be investigated. Also it has been revealed in the limited reports that pep­tidoleukotrienes may participate in the pathogenesis of aspirin-induced gastrotoxicity. In our experiments on rats using the method of adjuvant-induced arthritis it has been shown that peptidoleukotriene receptor block­ers montelukast sodium and zafirlukast produced antiinflammatory action (reduction of oedema) and antinociceptive effect (elevation of pain thresholds in the hot plate method). Used drugs had no effects in the tail-flick method. In experiments with montelukast it also has been shown that the drug reduced the ulcera­tive action of aspirin in stomach. The role of peptidoleukotrienes and their receptors in the regulation of inflam­matory pain thresholds and aspirin-induced gastrotoxicity is discussed.

About the authors

I. В. Marusova

The State Pavlov Medical University

Author for correspondence.
Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg

I. V. Marusov

The State Pavlov Medical University

Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg

Y. D. Ignatov

The State Pavlov Medical University

Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg

N. N. Petrishchev

The State Pavlov Medical University

Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg

References

  1. Игнатов Ю. Д, Мару сова И. Б., Марусов И. В., Пчелинцев М. В. Влияние блокатора Cys LT1 рецепторов монтелукаста на отек и болевую чувствительность при адъювантном артрите у крыс // Тез. докл. VII Российского национального конгресса «Человек и лекарство». М., 2000. 500 с.
  2. Amann R., Schuligoi R., Lanz I., Peskar B A. Effect of a 5-lipoxygenase inhibitor on nerve growth factor-induced thermal hyperalgesia in the rat // Europ. J. Pharmacol. 1996. Vol. 306 (1-3). P. 89-91.
  3. FaulerJ., Thon A., Tsikas D. etal. Enhanced synthesis of cysteinyl leukotrienes in juvenile rheumatoid arthritis // Arthrit. Rheumat. 1994. Vol. 37(1). P. 93-97.
  4. Fiorucci S., Santucci L.t Gresele P. et al. Effect of NSAIDs on pepsinogen secretion and calcium mobilization in isolated chief cells // Am. J. Physiol. 1995. Vol. 268(6 Pt 1). P. 968-978.
  5. GokS., OnalA., Cinar M. G., Evinc A. The antinociceptive effect of leukotriene D4 receptor antagonist, MK-571, in mice: possible involvement of opioidergic mechanism // Eur. J. Pharmacol. 1999. Vol. 386. Issue 2-3. P. 195-200.
  6. Qyomber E., Vattay P, Szabo S., Rainsford K. D. Effect of lipoxygenase inhibitors and leukotrieneantagonists on acute and chronic gastric haemorrhagic mucosal lesions in ulcer models in the rat // J. Gastroent. Hepat. 1996. Vol. 11(10). P. 922-927.
  7. LaitinenL., LaitinenA., HaahtelaT. et al. Leu¬kotriene E4 and granulocytic infiltration into asthmatic airways // Lancet. 1993. Vol. 341 (8851). P. 989-990.
  8. Larsen J. D., Acosta E. P Leukotriene-receptor antagonists and 5-lipoxygenase inhibitors in asthma // Ann. Pharmacother. 1993. Vol. 27 (7-8). P. 898-903.
  9. Levine J. D., LamD., Taiwo Y. O. et al. Hyper-algesic properties of 15-lipoxygenase products of arachidonic acid // Proc. Natl. Acad. Sci. USA. 1986. Vol. 83. P. 5331-5334.
  10. Mamot C., Hildebrand I. B., Olenik C. et al. Evidence for the involvement of 5-lipoxygenase products in the regulation of the expression of the proenkephalin gene in cultured astroglial cells // Brain Research. Molecular Brain Research. 1995. Vol. 33(1). P. 79-86.
  11. Martin H. A. Leukotriene B4 induced decrease in mechanical and thermal thresholds of C-fiber mechanonociceptors in rat hairy skin // Brain Research. 1990. Vol. 509(2). P. 273-279.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.